Renal Cell Carcinoma Perspective

 
 
  • Quiz: The Alcohol-Cancer Connection How much do you know about the link between alcohol and cancer and how this influences advice to patients?
  • 14th International Kidney Cancer Symposium (IKCS) Read clinically focused news coverage of key developments from IKCS 2015.
  • Patient Advocates Emerge as Key Stakeholders   Patient advocates have emerged as sophisticated stakeholders who understand the healthcare system and are knowledgeable about pertinent scientific developments in their disease area.
  • A Look at the Evidence: Diet, Exercise and Cancer Risk How much do diet and exercise affect cancer risk? At the ASCO 2015 annual meeting, an expert in cancer prevention discusses the weight of the evidence.
  • HBV: React Before the Virus Does This once-fatal condition can now be easily prevented, but to screen patients appropriately requires a level of awareness that is lacking at present.
  • The Patient as Research Partner Oncologists recall the critical role that patients have played in their research and clinical knowledge.
  • Recognize and Treat TKI-Induced Toxic Skin Effects Dr Graeme M. Lipper reviews a study that examined the prevalence and clinical spectrum of adverse skin reactions in patients treated with the chemotherapy drug cabozantinib.
  • Mythbusters: Does This Cause Cancer? Five commonly cited environmental cancer risks are investigated to determine how robust the link to cancer actually is.
  • NephMadness 2015: Onconephrology Learn about key concepts that overlap oncology with nephrology, and then use your knowledge to pick the 'winners' in the NephMadness Tournament.
  • Genitourinary Cancers Symposium (GUCS) 2015 Read clinically focused news coverage of key developments from GUCS 2015.
  • Perils and Pluses of 'Compassionate Use'   When a person is dying, there may be lots of pressure to give access to drugs still in development. This happened during the recent Ebola outbreak. But there are serious pros and cons to doing this.
  • Immuno Death Ray to GI Cancers   Can immunotherapy 'clip the force field' of gastrointestinal tumors? Dr John Marshall and experts say yes and will discuss advances during the Ruesch Symposium 2014, December 5, Washington, DC.
  • Refining Sunitinib Use Extends Survival in RCC   Dr Bernard Escudier highlights the renal cancer presentations from ESMO 2014, focusing on data on gene signatures, new uses of old drugs, and promising combinations to improve survival.
  • Urinary Biomarker for AKI Makes It to the Finish Line Is the search for an 'ECG of the kidney' finally over? Dr Szczech describes a new assay and the evidence supporting it.
  • Cancer Rates in Kids: Looking Behind the Numbers A recent study examined rates and trends in childhood cancers. Medscape spoke with the lead researcher.
  • CAR T Cells: A Look Under the Hood and Down the Road Lost your way in immunotherapy? Dr. Mark Adler provides clinicians a roadmap for navigating cancer immunotherapy and takes one of the most promising approaches -- CAR T cells -- for a test drive.
  • An Unused Curative Option in RCC? Dr. Gert De Meerleer discusses the use of stereotactic body radiation therapy (SBRT) to control and potentially cure limited metastatic disease in renal cell carcinoma.
  • Nivolumab Appears 'Promising' in RCC   Drs. Bernard Escudier and Nicholas Vogelzang highlight studies in kidney and bladder cancer presentations from ASCO 2014.
  • All-Out Assault on CRC   Drs. Louis Weiner and Axel Grothey discuss a multipronged strategy to increase survival in colorectal cancer and highlight data on other GI cancers presented at ASCO 2014.
  • Tailoring Therapy in Renal Cell Carcinoma How to make the choice of treatment options for patients with metastatic renal cell carcinoma? Dr. Viktor Grünwald, author of a recent review, sorts out the evidence.
https://www.apothekegenerika.com

http://steroid-pharm.com

www.medicaments-24.net/levitra-vardenafil/